Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia
Status:
Not yet recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
There is a variety of in vitro, in vivo (animal model), and human case series data which
suggests that the addition of ertapenem to cefazolin could improve outcomes in
methicillin-susceptible S. aureus bacteremia. No randomized controlled trial has been
performed.